Anti-proliferative and pro-apoptotic effects induced by simultaneous inactivation of HER1 and HER2 through endogenous polyclonal antibodies

The human epidermal growth factor receptor (HER1) and its partner HER2 are extensively described oncogenes and validated targets for cancer therapy. However, the effectiveness of monospecific therapies targeting these receptors is hampered by resistance emergence, which is frequently associated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Suárez, Narjara González, Báez, Gretchen Bergado, Rodríguez, Mabel Cruz, Pérez, Amelia Gutiérrez, García, Lisset Chao, Hernández Fernández, Diana Rosa, Pous, Judith Raymond, Ramírez, Belinda Sánchez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669935/
https://www.ncbi.nlm.nih.gov/pubmed/29137309
http://dx.doi.org/10.18632/oncotarget.19958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669935/
https://www.ncbi.nlm.nih.gov/pubmed/29137309
http://dx.doi.org/10.18632/oncotarget.19958

Ejemplares similares